Compounds > valproic acid

valproic acid and aee 788

valproic acid has been researched along with aee 788 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blaheta, RA; Engler, J; Hudak, L; Jonas, D; Jones, J; Juengel, E; Mickuckyte, A1
Blaheta, RA; Haferkamp, A; Hudak, L; Juengel, E; Oppermann, E; Seibel, JM; Wedel, S1
Blaheta, RA; Haferkamp, A; Hudak, L; Juengel, E; Makarević, J; Seibel, JM; Tsaur, I; Waaga-Gasser, A; Wedel, S1

Other Studies

3 other study(ies) available for valproic acid and aee 788

ArticleYear
Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.
    BJU international, 2010, Volume: 105, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Renal Cell; Cell Adhesion; Cell Line, Tumor; Drug Screening Assays, Antitumor; Endothelium, Vascular; Extracellular Matrix Proteins; Flow Cytometry; Humans; Integrin alpha Chains; Integrin beta Chains; Kidney Neoplasms; Purines; Valproic Acid

2010
Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
    The Prostate, 2011, May-15, Volume: 71, Issue:7

    Topics: Adenocarcinoma; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Protein Kinase Inhibitors; Purines; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Valproic Acid

2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
    BMC cancer, 2011, Aug-25, Volume: 11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Everolimus; Human Umbilical Vein Endothelial Cells; Humans; Integrins; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Purines; Signal Transduction; Sirolimus; Valproic Acid

2011